Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
6-HYDRAZINOADENOSINE COMPOUND HAVING A2A ADENOSINE RECEPTOR AGONIST ACTIVITY
Document Type and Number:
WIPO Patent Application WO/2020/253870
Kind Code:
A1
Abstract:
The present disclosure provides 6-hydrazinoadenosine having A2A adenosine receptor agonistic activity represented by general formula (I) and a derivative thereof, and a pharmaceutical composition containing same. The compound and composition can be used as an A2A adenosine receptor agonist as a medicament.

Inventors:
ZHONG WU (CN)
ZHANG MIN (CN)
ZHOU XINBO (CN)
FAN SHIYONG (CN)
LI SONG (CN)
Application Number:
CN2020/097427
Publication Date:
December 24, 2020
Filing Date:
June 22, 2020
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
ACAD OF MILITARY MEDICAL SCIENCES (CN)
International Classes:
C07D473/34; A61K31/7076; A61P37/06; C07H19/167
Domestic Patent References:
WO2011123518A12011-10-06
Foreign References:
US20120329747A12012-12-27
CA952102A1974-07-30
Other References:
CHEN, HUIJUN ET AL.: "Novel Synthesis of 7-β-D-Ribofuranosyl-7H-1,2,4-triazolo[3,4-i]purines with Use of NBS", SYNTHETIC COMMUNICATIONS, vol. 36, no. 4, 31 December 2006 (2006-12-31), XP055767116, ISSN: 0039-7911, DOI: 20200910162905X
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: